Clinical Trials Resource Center

Welcome to the Sarcoma Foundation of America's Clinical Trials Resource Center presented in partnership with CenterWatch.com, the leading publisher of information on clinical research for patients and their advocates. Please click on the links below to learn more about clinical research and new medical therapies.

Actively Recruiting Clinical Trials*

*for a comprehensive list, please go to the Patient Resource section below.

Information that may be helpful for People Diagnosed with Metastatic Sarcoma regarding the SUCCEED Clinical Trial Currently Enrolling Patients

ARIAD Pharmaceuticals has launched an international Phase 3 clinical trial of deforolimus, a novel mTOR inhibitor, in patients with metastatic soft-tissue and bone sarcomas.  Patients who are currently receiving chemotherapy for the treatment of their sarcoma may wish to discuss the SUCCEED trial with their doctors to see if it may be right for them.  For more information about the trial or to find a trial site nearby, you can visit www.succeedtrial.com or call toll-free 1-877-621-2302 or internationally 1-617-621-2302 or email at ClinicalTrials@ARIAD.com

Sarcoma Alliance for Research through Collaboration (SARC)

SARC is a non-profit organization providing the infrastructure for collaboration between physicians, researchers, and medical institutions from across the world who are engaged in clinical research for development of new standards of patient treatment, education, and prevention. To find out more about SARC and a listing of our current clinical trials, please go to http://www.sarctrials.org/public/pag53.aspx.

Brostallicin Clinical Trial for Myxoid Liposarcoma

Pharmatech, Inc. is managing a clinical trial sponsored by Systems Medicine, LLC.  The trial is a Phase 2 open-label clinical study of an experimental drug called Brostallicin, for the treatment of patients with myxoid liposarcoma with a (12;16) translocation. The cancer must be metastatic or unresectable and standard curative or palliative measures do not exist or are not effective. Patients with myxoid liposarcoma may wish to discuss the Brostallicin trial with their doctors to see if it may be right for them.  For more information about the trial and to find a participating trial site, please visit www.pharmatech.com/clinicaltrials.html or call 1-866-383-6610 x160 or email info2@pharmatech.com.

ARQ 197-204 for Clear Cell and Alveolar Soft Part Sarcomas

Arqule Inc., in cooperation with the Dana Farber Cancer Institute, Texas Children’s Cancer Center, Mary Crowley Medical Research Center, Cincinnati Children's Hospital, University of California San Francisco, and Premiere Oncology, is sponsoring a multi-center, single arm (non-comparative) phase 2 clinical trial evaluating the use of ARQ 197 in patients with microphthalmia transcription factor, or MiT, associated tumors.  These MiT tumors include clear cell sarcoma, alveolar soft part sarcoma, and translocation associated renal cell carcinoma.  This trial, ARQ 197-204, is currently open, active, and enrolling patients. Further information on this clinical trial, as well as information on enrollment, can be acquired here.  Alternatively, patients or families can call Dora Ferrari at 781-994-0416.

Patient Resources

  • About Clinical Research
    Background information about the clinical trials process and what to expect when you volunteer to participate in a clinical trial. Here, you'll find answers to frequently asked questions about clinical trials and also suggestions for where to find more information.
  • CenterWatch Clinical Trials Listing Service
    Database of industry sponsored clinical trial listings for Sarcoma.
  • Listing of Studies at ClinicalTrials.gov
    Link to ClinicalTrials.gov, a comprehensive listing of federally and privately supported clinical trials. The U.S. National Institutes of Health (NIH), through its National Library of Medicine (NLM), has developed this site in collaboration with the Food and Drug Administration (FDA).
  • Profiles of Research Centers
    Detailed descriptions of centers that conduct clinical research in the field of Oncology. Profiles include an overview of each center, descriptions of clinical research investigators and staff, and links to currently enrolling clinical research studies.
  • New FDA Drug Approvals
    Database of new medical treatments approved by the FDA since 1995. Detailed summary descriptions for each drug are provided including drug name; manufacturer; mechanism of action; clinical trial results, and side effect profile.
  • CenterWatch Research Headlines
    Here you'll find links to news articles and reports on recent advances in clinical research. This section is updated weekly and the information has been published in CenterWatch publications during the past weeks.
  • CenterWatch Bookstore
    Descriptions of all of CenterWatch's publications for patients and for clinical research professionals.
  • Coalition of National Cancer Cooperative Groups
    The Coalition's website provides a wealth of information about cancer clinical trials. Website features include:
    • TrialCheck, a clinical trials search engine
    • Cancer Research: A Guide to Cancer Clinical Trials, an interactive educational program
    • Print materials for ordering
    • Discussion with oncology experts
    • Patient discussion forum

  • Clinical Trials search site  - the NCI has developed this premier site.  Just type in osteosarcoma, soft tissue sarcoma, etc., or refine the search to your personal interests

  • CancerTrialsHelp.org - this site supplements the NCI site above a little bit, but is incomplete so should not be your sole search site